CHARLES SCHWAB INVESTMENT MANAGEMENT INC - ASSERTIO THERAPEUTICS INC ownership

ASSERTIO THERAPEUTICS INC's ticker is ASRT and the CUSIP is 04545L107. A total of 163 filers reported holding ASSERTIO THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.22 and the average weighting 0.0%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of ASSERTIO THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$285,000
-47.2%
437,737
+1.5%
0.00%
Q4 2019$540,000
-35.9%
431,233
-34.4%
0.00%
Q3 2019$842,000
-54.7%
657,325
+22.1%
0.00%
-100.0%
Q2 2019$1,858,000
-34.0%
538,437
-3.0%
0.00%
-50.0%
Q1 2019$2,816,000
+56.4%
555,343
+11.4%
0.00%
+100.0%
Q4 2018$1,801,000
-29.9%
498,732
+14.1%
0.00%
-50.0%
Q3 2018$2,570,000437,0390.00%
Other shareholders
ASSERTIO THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
PERKINS CAPITAL MANAGEMENT INC 120,600$416,0000.29%
Matarin Capital Management, LLC 762,489$2,631,0000.19%
DELTEC ASSET MANAGEMENT LLC 204,513$706,0000.16%
GLOBEFLEX CAPITAL L P 213,991$738,0000.15%
TSP Capital Management Group, LLC 88,750$306,0000.14%
Spark Investment Management LLC 512,500$1,768,0000.12%
OXFORD ASSET MANAGEMENT LLP 1,141,332$3,938,0000.08%
ALGERT GLOBAL LLC 66,842$231,0000.08%
CIGNA INVESTMENTS INC /NEW 188,018$645,0000.07%
Connor, Clark & Lunn Investment Management Ltd. 3,103,949$10,709,0000.07%
View complete list of ASSERTIO THERAPEUTICS INC shareholders